Literature DB >> 32952692

Cytomegalovirus Infection in Pregnancy - Counselling Challenges in the Setting of Generalised Testing.

Anca Maria Ciobanu1, Nicolae Gica1, Corina Gica1, Radu Botezatu1, Mirona Furtuna1, Gheorghe Peltecu1, Anca Maria Panaitescu1.   

Abstract

Cytomegalovirus (CMV) is the most common cause of perinatal viral infection, affecting 0.2-2.2% of all neonates, with variation among different study populations. It can cause serious long-term neurological sequelae, being the leading cause of non-genetic congenital hearing loss. The risk of congenital infection is highest after primary maternal infection, varying between 30-70% and depending on the gestational age at the time of infection. Although CMV can have serious neurodevelopmental consequences, in most developed countries current guidelines do not recommend routine screening for CMV in pregnancy, since current tests have a low predictive value for cases with serious adverse outcome and efficient therapeutic options are not standardized yet. In Romania there is a routine clinical practice to offer screening for most common causes of infections, including CMV, in the first trimester of pregnancy In these settings, this review summarizes the current methods of diagnosis and management of CMV infection in pregnancy.

Entities:  

Year:  2020        PMID: 32952692      PMCID: PMC7482684          DOI: 10.26574/maedica.2020.15.2.253

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  28 in total

1.  Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age.

Authors:  Silvia Visentin; Renzo Manara; Laura Milanese; Anna Da Roit; Gabriella Forner; Eleonora Salviato; Valentina Citton; Fioretta Marciani Magno; Eva Orzan; Carla Morando; Riccardo Cusinato; Carlo Mengoli; Giorgio Palu; Mario Ermani; Roberto Rinaldi; Erich Cosmi; Nadia Gussetti
Journal:  Clin Infect Dis       Date:  2012-04-26       Impact factor: 9.079

2.  Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population.

Authors:  Aparecida Y Yamamoto; Marisa Marcia Mussi-Pinhata; Myriam de Lima Isaac; Fabiana R Amaral; Cristina G Carvalheiro; Davi C Aragon; Alessandra K da Silva Manfredi; Suresh B Boppana; William J Britt
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

3.  Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women.

Authors:  L Grangeot-Keros; M J Mayaux; P Lebon; F Freymuth; G Eugene; R Stricker; E Dussaix
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

4.  In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study.

Authors:  Marianne Leruez-Ville; Idir Ghout; Laurence Bussières; Julien Stirnemann; Jean-François Magny; Sophie Couderc; Laurent J Salomon; Tiffany Guilleminot; Philippe Aegerter; Guillaume Benoist; Norbert Winer; Olivier Picone; François Jacquemard; Yves Ville
Journal:  Am J Obstet Gynecol       Date:  2016-04-13       Impact factor: 8.661

Review 5.  Congenital cytomegalovirus (CMV) infection and hearing deficit.

Authors:  Karen B Fowler; Suresh B Boppana
Journal:  J Clin Virol       Date:  2005-12-28       Impact factor: 3.168

6.  Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.

Authors:  S B Boppana; L B Rivera; K B Fowler; M Mach; W J Britt
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

Review 7.  Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature.

Authors:  Michael A Gaytant; G Ingrid J G Rours; Eric A P Steegers; Jochem M D Galama; Ben A Semmekrot
Journal:  Eur J Pediatr       Date:  2003-02-13       Impact factor: 3.183

8.  Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.

Authors:  David W Kimberlin; Chin-Yu Lin; Pablo J Sánchez; Gail J Demmler; Wayne Dankner; Mark Shelton; Richard F Jacobs; Wendy Vaudry; Robert F Pass; Jan M Kiell; Seng-jaw Soong; Richard J Whitley
Journal:  J Pediatr       Date:  2003-07       Impact factor: 4.406

9.  Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system.

Authors:  Sara E Oliver; Gretchen A Cloud; Pablo J Sánchez; Gail J Demmler; Wayne Dankner; Mark Shelton; Richard F Jacobs; Wendy Vaudry; Robert F Pass; Seng-jaw Soong; Richard J Whitley; David W Kimberlin
Journal:  J Clin Virol       Date:  2009-09-18       Impact factor: 3.168

10.  The outcome of congenital cytomegalovirus infection in relation to maternal antibody status.

Authors:  K B Fowler; S Stagno; R F Pass; W J Britt; T J Boll; C A Alford
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.